GLP-1 weight-loss drugs

Doctors, including DR SHEILA, are raising concerns about the long-term use of Ozempic, a GLP-1 weight-loss drug, particularly its effects on young patients.

Gen X, already leading Botox and filler use, is increasingly opting for facelifts a decade earlier due to 'Ozempic face' caused by GLP-1 weight-loss drugs, which accelerate facial aging through volume loss and sagging. Surgeons report a 50% rise in fat-grafting procedures in 2024 linked to this trend, with Gen X patients in their 40s and 50s now seeking surgical treatments typically reserved for older age groups.

The rising use of GLP-1 weight-loss drugs is influencing fashion and food industries, with clothing brands adjusting designs for body fluctuations and wedding retailers requiring size waivers. An HSBC report warns reduced food expenditures could cut consumer spending by 7% in regions with high obesity rates like Eastern Europe, Latin America, and the US.

Researchers analyzed 400,000 Reddit posts and found that users of GLP-1 weight-loss drugs like Ozempic frequently reported unexpected side effects such as menstrual irregularities, chills, and hot flashes. The study highlights AI's potential to use social media as an early-warning system for identifying overlooked drug side effects.

GLP-1 weight-loss drugs like Ozempic and Wegovy may lead to judgment due to perceptions of being an 'easy way out'. People who lose weight using these medications face stigma rooted in societal expectations. This stigma creates a double bind where individuals are judged for their weight and how they manage it.

Hershey is experiencing increased sales of mints and gum due to 'Ozempic breath,' a side effect of GLP-1 weight-loss drugs that has led consumers to opt for breath-freshening products while reducing overall snacking.